The body often reverts to its previous metabolic set point, making regain more likely without continued intervention
However, significant limitations exist in the current evidence: Most human data comes from small studies, with limited randomised controlled trials specifically designed to assess alcohol consumption The mechanisms by which GLP-1 medications might reduce alcohol intake are not fully understood Individual responses vary considerably, and not all patients experience changes in drinking behaviour Long-term effects and safety of using these medications specifically for alcohol reduction remain unknown The MHRA has not approved GLP-1 receptor agonists for alcohol use disorder, and these medications should not be considered a treatment for problematic drinking
These are general timeframes, not a rule, and your care team sets your actual date
Address behavioral and psychological factors , such as stress or emotional eating, that may impact weight management
It supports overall vitality, cognitive sharpness, and physical functionality, making you feel, think, and function younger
Common formulations include 0.5 to 1.0 mg (500 to 1000 mcg) b12 per semaglutide dose
